The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 185-194

  Abe, Yuko ^a   Fujii, Ken ^a   Nagata, Noriyo ^b   Takeuchi, Osamu ^c   Akira, Shizuo ^c   Oshiumi, Hiroyuki ^d   Matsumoto, Misako ^d   Seya, Tsukasa ^d   Koike, Satoshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; VIRUS RECEPTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HOST RESISTANCE; IN VITRO STUDY; INFECTION PREVENTION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PICORNAVIRUS; POLIOMYELITIS; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS LOAD; VIRUS REPLICATION; WILD TYPE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; FEMALE; HUMANS; INTERFERON TYPE I; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; POLIOMYELITIS; POLIOVIRUS; RECEPTORS, VIRUS; TOLL-LIKE RECEPTOR 3;

MUS; MUS MUSCULUS; POLIOVIRUS;

EID: 84855954760     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05245-11     Document Type: Article

References (55)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor Nature 413:732-738.
3. Barral PM, et al. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677-3684.
4. Bodian D. 1959. Poliomyelitis: pathogenesis and histopathology, p 479-518. InRivers TM, Horsfall FL, Jr (ed), Viral and rickettsial infections of man, vol 3. J. B. Lippincott, Philadelphia, PA.
5. Cella M, et al. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919 -923.
6. Choe SS, Dodd DA, Kirkegaard K. 2005. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337:18 -29.
7. Colonna M, Trinchieri G, Liu YJ. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219 -1226.
8. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 303:1529 -1531.
9. Edelmann KH, et al. 2004. Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231-238.
10. Gitlin L, et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459-8464.
11. Hardarson HS, et al. 2007. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 292:H251-H258.
12. Hemmi H, et al. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3:196 -200.
13. Hoebe K, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743-748.
14. Holland JJ. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15:312-326.
15. Holland JJ, Mc LL, Syverton JT. 1959. Mammalian cell-virus relationship. III. Poliovirus production by non-primate cells exposed to poliovirus ribonucleic acid. Proc. Soc. Exp. Biol. Med. 100:843-845.
16. Holland JJ, McLaren LC, Syverton JT. 1959. The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J. Exp. Med. 110:65-80.
17. Hornung V, et al. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994 -997.
18. Hsiung GD, Black FL, Henderson JR. 1964. Susceptibility of primates to viruses in relation to taxonomic classification, p 1-23. InBuettner-Jaenusch J (ed), Evolutionary and genetic biology of primates, vol 2. Academic Press, New York, NY.
19. Ida-Hosonuma M, et al. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79: 4460-4469.
20. Ida-Hosonuma M, et al. 2003. Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution. Arch. Virol. 148:29-44.
21. Kato H, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19 -28.
22. Kato H, et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205:1601-1610.
23. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
24. Koike S, et al. 1992. A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J. Virol. 66:7059 -7066.
25. Koike S, Nomoto A. 2010. Poliomyelitis, p 339 -351. InEhrenfeld E, Domingo E, Roos RP (ed), The picornaviruses. ASM Press, Washington, DC.
26. Koike S, et al. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. U. S. A. 88:951-955.
27. Kramer M, et al. 2008. Phagocytosis of picornavirus-infected cells induces an RNA-dependent antiviral state in human dendritic cells. J. Virol. 82:2930 -2937.
28. Matsumoto M, et al. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171:3154 -3162.
29. Matsumoto M, Oshiumi H, Seya T. 2011. Antiviral responses induced by the TLR3 pathway. Rev. Med. Virol. 21:67-77.
30. Negishi H, et al. 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. U. S. A. 105:20446-20451.
31. Ohka S, et al. 2004. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J. Virol. 78: 7186-7198.
32. Ohka S, et al. 2009. Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J. Virol. 83:4995-5004.
33. Ohka S, Yang WX, Terada E, Iwasaki K, Nomoto A. 1998. Retrograde transport of intact poliovirus through the axon via the fast transport system. Virology 250:67-75.
34. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:161-167.
35. Oshiumi H, et al. 12 October 2011, posting date. The TLR3-TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol. [Epub ahead of print.] doi:10.4049/jimmunol.1101503.
36. Pichlmair A, et al. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001.
37. Pichlmair A, et al. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83:10761-10769.
38. Racaniello VR. 2007. Picornaviridae: the viruses and their replication, p 795-838. InKnipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
39. Rebsamen M, Meylan E, Curran J, Tschopp J. 2008. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ. 15:1804 -1811.
40. Ren RB, Costantini F, Gorgacz EJ, Lee JJ, Racaniello VR. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
41. Riad A, et al. 2011. TRIF is a critical survival factor in viral cardiomyopathy. J. Immunol. 186:2561-2570.
42. Richer MJ, Lavallee DJ, Shanina I, Horwitz MS. 2009. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One 4:e4127.
43. Schröder M, Bowie AG. 2005. TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26:462- 468.
44. Schulz O, et al. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887- 892.
45. Shiroki K, et al. 1995. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J. Virol. 69: 6825-6832.
46. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol. Rev. 227:75-86.
47. Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20:17-22.
48. Takeuchi O, Akira S. 2007. Recognition of viruses by innate immunity. Immunol. Rev. 220:214 -224.
49. Wang Q, et al. 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183:6989-6997.
50. Wang T, et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366 -1373.
51. Yamamoto M, et al. 2003. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301:640-643.
52. Yang WX, et al. 1997. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 229:421- 428.
53. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730 -737.
54. Yoshikawa T, et al. 2006. Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J. Virol. 80:4313- 4325.
55. Yousefi S, Escobar MR, Gouldin CW. 1985. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am. J. Clin. Pathol. 83:735-740.